# Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

> **NCT00919555** · PHASE1,PHASE2 · COMPLETED · sponsor: **Phoenix Neurological Associates, LTD** · enrollment: 28 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Pioglitazone and Tretinoin
- **DRUG:** Tretinoin and Pioglitazone HCL
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00919555
- **Lead sponsor:** Phoenix Neurological Associates, LTD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-11
- **Final completion:** 2012-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919555, "Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00919555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*